- By Billy Chen
- Posted June 25, 2018
Coming of Age: Whole Exome Sequencing
Whole exome sequencing (WES) is an efficient way to identify genetic variants in all of an individual's genes. It does this by sequencing the functionally relevant regions of approximately 20,000 genes of the human genome. Compared to traditional genetic testing trajectory, which tends to be more time-consuming, recent studies indicate WES can…
- By Brooke Overstreet, MS, CGC
- Posted May 15, 2018
Increase the Detection of Patients with Hereditary Cancer
Identifying patients with hereditary cancer is critical, so that you can gather additional information for personalized risk counseling and management planning. The first step is to use personal and family history information to find out which patients may be candidates for genetic testing. With tools like our hereditary cancer questionnaire,…
- By Kelly D. F. Hagman, MS, CGC
- Posted May 11, 2018
Free CEUs For Genetic Counselors | EducateNext
For years, Ambry has been offering educational webinars to our employees as a way to make sure genetic counselors across multiple functions within the company were always up to date on the latest research. Now, we are opening up this program to all genetics professionals, in the form of a new program called EducateNext. This program will present…
- By Stephany Tandy-Connor, MS
- Posted March 28, 2018
Genetic testing at home or from the doctor’s office – same difference?
There has been a lot of talk about Direct-To-Consumer (DTC) genetic testing and the caveats that come along with that type of testing, but what does it all really mean? What is the actual difference between a DTC genetic test and a genetic test ordered by a medical professional through a clinical laboratory? There are several things that make…
- By Stephany Tandy-Connor, MS
- Posted March 22, 2018
False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care
The explosion of direct-to-consumer genetic testing over the last few years has created a ton of buzz, beyond just ancestry, health traits and wine preferences. Many of these DTC labs also release raw data to the consumer; this often leaves many individuals interested in what these findings mean and their potential impact on their healthcare management.…
- By Jessica Profato, MS, CGC
- Posted February 15, 2018
Using Family History to Guide Cancer Prevention
There are many factors that impact your patients’ risk to develop certain cancers, including whether or not they have a family history of the disease, which can significantly impact the likelihood they may develop cancers such as breast, colorectal, and prostate. Individuals with a strong family history of cancer may have a hereditary cancer…
- By David Pfeifer
- Posted December 18, 2017
Have a Little Heart: The Growing Segment of Cardiovascular Genetics
From consumers, to physicians to genetic counselors, the importance of heart health is taking center stage in genetics. Clinicians from all specialties are recognizing the benefits of cardiovascular genetic testing; inherited arrhythmias, cardiomyopathies, thoracic aortic aneurysms, and familial hypercholesterolemia are becoming more commonly discussed…
- By Aaron Schmidt
- Posted December 18, 2017
Ambry Celebrates a Milestone Year
Ambry Celebrates a Milestone Year Ambry is looking forward to an exciting 2018, after experiencing a year of reaching important milestones and seeing many changes in 2017. From joining the Konica Minolta family, to the launch of our paired testing in our mission to understand all disease, to say it was a busy year is an understatement. Test Launches…
- By Billy Chen
- Posted December 13, 2017
Finding Answers to Neurological Disorders with Clinical Exome Sequencing
At Ambry, “Finding Answers” is at the core of what we do. We know patients and clinicians depend on us to find answers that help them better understand diseases, and improve outcomes. 2017 has been a busy and productive year for Ambry. In particular, using Ambry’s clinical exome test, ExomeNext, we have been successful in identifying…
- By Jessica Profato, MS, CGC
- Posted December 6, 2017
How Ambry Affected Hereditary Cancer Testing in 2017
It has been an exciting and busy year at Ambry Genetics, packed with steps forward on our path towards understanding all human disease. We have continued our dedication, not only to quality testing, but to innovation, research, and patient advocacy. As we reach the end of 2017, we look forward to an even more impactful 2018 and working together…